|
Market Closed -
Other stock markets
|
Pre-market 10:24:05 pm | |||
| 53.27 USD | +0.74% |
|
53.46 | +0.36% |
| 13/05 | Moderna, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 11:20 AM | |
| 13/05 | Trump says US FDA Commissioner Makary is out | RE |
Company Valuation: Moderna, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 102,976 | 69,006 | 37,919 | 16,001 | 11,523 | 21,137 | - | - |
| Change | - | -32.99% | -45.05% | -57.8% | -27.99% | 83.44% | - | - |
| Enterprise Value (EV) 1 | 92,848 | 59,104 | 29,315 | 8,976 | 5,724 | 17,577 | 18,864 | 19,241 |
| Change | - | -36.34% | -50.4% | -69.38% | -36.23% | 207.1% | 7.32% | 2% |
| P/E ratio | 8.98x | 8.93x | -8.07x | -4.48x | -4.06x | -6.16x | -11.3x | -18.7x |
| PBR | 7.24x | 3.7x | 2.74x | 1.46x | 1.33x | 3.74x | 5.14x | 6.06x |
| PEG | - | -0.3x | 0x | 0.2x | 0.2x | -0.3x | 0.2x | 0.5x |
| Capitalization / Revenue | 5.58x | 3.58x | 5.54x | 4.94x | 5.93x | 10.1x | 8.36x | 6.58x |
| EV / Revenue | 5.03x | 3.07x | 4.28x | 2.77x | 2.94x | 8.43x | 7.46x | 5.99x |
| EV / EBITDA | 6.86x | 6.05x | -8.1x | -2.39x | -2x | -5.13x | -10.5x | -18.5x |
| EV / EBIT | 6.98x | 6.27x | -6.92x | -2.28x | -1.86x | -4.86x | -9.44x | -15.9x |
| EV / FCF | 6.96x | 12.9x | -7.66x | -2.21x | -2.77x | -5.67x | -12.7x | -15x |
| FCF Yield | 14.4% | 7.75% | -13% | -45.2% | -36.1% | -17.6% | -7.86% | -6.65% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 28.29 | 20.12 | -12.33 | -9.28 | -7.26 | -8.653 | -4.727 | -2.852 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,471 | 19,263 | 6,848 | 3,236 | 1,944 | 2,086 | 2,529 | 3,213 |
| EBITDA 1 | 13,528 | 9,768 | -3,618 | -3,756 | -2,859 | -3,425 | -1,800 | -1,038 |
| EBIT 1 | 13,296 | 9,420 | -4,239 | -3,945 | -3,074 | -3,616 | -1,997 | -1,207 |
| Net income 1 | 12,202 | 8,362 | -4,714 | -3,561 | -2,822 | -3,409 | -1,839 | -1,148 |
| Net Debt 1 | -10,128 | -9,902 | -8,604 | -7,025 | -5,799 | -3,559 | -2,273 | -1,895 |
| Reference price 2 | 253.98 | 179.62 | 99.45 | 41.58 | 29.49 | 53.27 | 53.27 | 53.27 |
| Nbr of stocks (in thousands) | 405,450 | 384,180 | 381,284 | 384,818 | 390,734 | 396,786 | - | - |
| Announcement Date | 24/2/22 | 23/2/23 | 22/2/24 | 14/2/25 | 13/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.16x | 8.43x | -5.13x | -.--% | 21.14B | |
| 18.73x | 4.18x | 11.26x | 0.54% | 73.6B | |
| 26.18x | 5.26x | 15.16x | 0.6% | 53.86B | |
| 35.06x | 11.96x | 22.19x | -.--% | 44.71B | |
| -128.06x | 2.8x | 8.26x | 4% | 34.53B | |
| 32.19x | 3.5x | 10.42x | -.--% | 29.43B | |
| 15.02x | 2.63x | 8.17x | -.--% | 19.8B | |
| 51.96x | 6.55x | 45.58x | -.--% | 19.66B | |
| 24.18x | 5.09x | 13.72x | -.--% | 16.3B | |
| -30.51x | 14.45x | -38.97x | -.--% | 12.92B | |
| Average | 3.86x | 6.48x | 9.07x | 0.52% | 32.59B | |
| Weighted average by Cap. | 6.35x | 5.99x | 11.96x | 0.65% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- MRNA Stock
- Valuation Moderna, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition